In addition, in patients with advanced EGFR mutated NSCLC, co-alterations of cell cycle genes, such as CCND1/2, CCNE1, CDK4/6 were significantly associated with intrinsic resistance to osimertinib [28]. Here, EGFR is linked to non-small cell lung carcinoma.